Trade Summary

3 months ago, Lu Hongbo, serving as Dir at Zenas Biopharma, Inc. (ZBIO), purchased 3,768 shares at $18.63 per share, for a total transaction value of $70,198.00. Following this transaction, Lu Hongbo now holds 426,736 shares of ZBIO.

This purchase represents a 1.00% increase in Lu Hongbo's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 31, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026 (accepted Mar 31, 5:00 PM ET), 2 days after the trade was made.

Zenas Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.